4//SEC Filing
Requadt Scott 4
Accession 0001209191-23-041610
CIK 0001827506other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 5:19 PM ET
Size
6.2 KB
Accession
0001209191-23-041610
Insider Transaction Report
Form 4
Requadt Scott
DirectorSee Remarks
Transactions
- Tax Payment
Common Stock
2023-07-03$3.08/sh−11,786$36,301→ 578,403 total
Holdings
- 449,766(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]The restricted stock units ("RSUs") were granted to the Reporting Person by the issuer under the Issuer's 2021 Stock Option and Incentive Plan on September 10, 2022. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest as to 50% of the underlying shares on July 1, 2023 and the remaining 50% on July 1, 2024, subject to the Reporting Person's continued service on each such vesting date. This transaction reflects the sufficient shares sold to pay applicable income taxes related to the 50% vesting on July 1, 2023.
- [F2]These shares are held by Requadt Family Limited Partnership. The reporting person has voting and dispositive power over the shares beneficially owned by Requadt Family Limited Partnership.
Documents
Issuer
Talaris Therapeutics, Inc.
CIK 0001827506
Entity typeother
Related Parties
1- filerCIK 0001664852
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 5:19 PM ET
- Size
- 6.2 KB